A recent meta-analysis conducted by researchers at the University of New South Wales in Australia has revealed that older adults with untreated high blood pressure are at a significantly higher risk of developing Alzheimer’s disease. The study, published in Neurology, found that people aged 60 and older with untreated hypertension…

A population-based study from Sweden indicates that children and teenagers who were overweight or have obesity are more likely to have high blood pressure in later adult years from 50 to 64 years of age. The research, to be presented at the upcoming European Congress on Obesity (ECO) next month…

Preliminary findings of a longitudinal study aimed at better understanding geographic and ethnic differences in stroke incidence, which began enrolling patients 20 years ago, has identified a metabolite biomarker called gluconic acid. The biomarker is associated with high blood pressure, increased risk of ischemic stroke, eating a Southern diet, lower…

Results from a large Danish study suggest that children of mothers who experience disorders that include high blood pressure during pregnancy are at increased risk of dying in childhood or early adulthood. Hypertensive disorders of pregnancy (HDP) impact around 10% of pregnancies around the world. HDP refers to several conditions…

Results from a large genetic association study show individuals with a genetic propensity to high systolic blood pressure and high-density lipoprotein (HDL) cholesterol are at increased risk for developing Alzheimer’s disease. As both of these risk factors are potentially modifiable, the authors of the paper describing the research published in…

It is well known that so-called “hyperactive” blood platelets can result in abnormal blood clotting and an increased risk of heart attack, stroke, and peripheral artery disease. But measuring the clumping tendency—called aggregometry—to develop accurate patient risk assessments is not currently possible due to broad variations in lab testing methods.…

A record analysis of roughly 30,000 nursing home residents has revealed that blood pressure drugs more than double the risk of life-threatening bone fractures. The study from investigators at Rutgers Health, which appears in the journal JAMA Internal Medicine, reveals that higher risk is a result of blood pressure medications’…

A team of researchers from around the world, who are part of the International Consortium of Blood Pressure, have discovered more than 100 new regions in the human genome that seem to influence a person’s blood pressure. These findings enabled the researchers to improve polygenic risk scores to be more…

Research led by Kaiser Permanente Northern California shows controlling blood pressure in older menstruating women could help prevent the formation of uterine fibroids. As reported in JAMA Network Open, Susanna Mitro, PhD, a researcher at Kaiser Permanente Northern California, and colleagues found untreated or new hypertension increased new fibroid risk…

A link has been established between earlier menopause, higher risk of cardiovascular disease (CVD), and cognitive problems later in life, in a new study published in Neurology. These Canadian researchers looked at whether age at menopause, vascular risk, and history of hormone therapy (HT) containing estrogens together influence cognition over…

“Cradle-to-grave” disease trajectories could help identify critical events that lead to the diagnosis of a particular condition many decades later, a study suggests. The research could help integrate a person’s particular pathway in life into clinical decision-making, say the investigators. The findings, in the Nature journal npj Digital Medicine, could…

An RNAi-based treatment helps control blood pressure for several months in patients who are on standard of care, according to new Phase II trial results. Roche and Alnylam’s zilebesiran is given as a single injection and its long-lasting effects could be a boon, especially in patients whose blood pressure is…

Research from the Fred Hutchinson Cancer Center and the University of Washington (UW) have discovered that different combinations of medications can significantly lower blood pressure in patients who receive the cancer drug ibrutinib. The research, published in the journal Blood Advances, notes that patients receiving ibrutinib and other drugs in…

Remote diagnostics company Nanowear announced on Thursday that its nanotechnology-enabled wearable remote monitoring device and its SimpleSense platform received FDA 510(k) clearance as a continuous blood pressure monitor. SimpleSense-BP is a novel Softwear-as-a-Medical Device (SaMD) platform that combines the company’s proprietary cloth-embedded nanotechnology sensors and its artificial intelligence (AI) and…

Results from a study led by Radboud University Medical Center in the Netherlands shows frequent changes in blood pressure only increase dementia risk in people who are 90 years or older. However, the findings showed that individuals between the age of 60 and 89 with high blood pressure variability did…